TabacaleraYsidron Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

TabacaleraYsidron General Information


Mount TAM Biotechnologies Inc is a biopharmaceutical company operating in the US. Its core business is to optimize, develop a portfolio of products focused on improving the health and wellbeing of individuals afflicted with serious diseases, with a key product targeting systemic lupus erythematosus (SLE) and a strategy to bring to market novel therapeutics across a range of serious disease areas. The company mainly focuses on the development of a product candidate in the field of SLE, an autoimmune disorder where treatments are inadequate to control disease and a condition where serious unmet need remains. It product candidates is TAM-01 and TAM-03 which are novel rapalogs in action of binding and inhibition of the mammalian Target of Rapamycin.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Consumer Non-Durables
Primary Office
  • 100 Europa Drive
  • Suite 455
  • Chapel Hill, NC 27517
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TabacaleraYsidron Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TabacaleraYsidron‘s full profile, request access.

Request a free trial

TabacaleraYsidron Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Mount Tam Biotechnologies 14-Aug-2015 0000000 00 Pharmaceuticals
To view TabacaleraYsidron’s complete acquisitions history, request access »